Summary: Myofibroblast expansion is a critical event in the pathogenesis of liver fibrosis. The activation of hepatic stellate cells (HSC) to myofibroblast (MFB) results in the enhanced production of extracellular matrix (ECM). In this study, we explored the effect of acidic fibroblast growth factor (FGF-1) treatment on a transforming growth factor (TGF-β1) induced MFB conversion. We used HSC-T6 cell line, which represents well-established model of activated HSC. These cells strongly expressed α-smooth muscle actin (α-SMA) and fibronectin (FN-EDA) after stimulation with TGF-β1, which is a stimulus for MFB differentiation and ECM production. FGF-1 reduced proteins expression to levels comparable with untreated cells. Mild repression of secreted gelatinases was seen in culture media after FGF-1 treatment. The exposure of cells to collagen gel leads to changes in cell morphology and in expression of MFB markers. Lack of α-SMA in cells embedded to collagen gel was detected. When stimulated with TGF-β1, the cells increased expression of FN-EDA, but not α-SMA. Although the cells on plastic and in collagen gel show different properties, FGF-1 reduced expression of FN-EDA in both conditions. Disrupting TGF-β1 signalling pathway represents a potential strategy for the treatment of fibrosis. We showed that FGF-1 could antagonize signals initiated by TGF-β1.
Introduction
Hepatic fibrosis is characterized by the excessive deposition of extracellular matrix (ECM). Liver fibrosis was considered to be an irreversible process in the past. Currently it is regarded as a dynamic process arising due to a failure of the normal wound healing. Hepatic stellate cells (HSC), major effector cells, can be activated by many inflammatory cytokines and undergo a myofibroblastic differentiation. Activated HSC are called myofibroblast, because they express high levels of α-smooth muscle actin (α-SMA) and display the ability to contract ECM. While quiescent HSC cells do not synthetize any ECM proteins (3, 13) , the activation of MFB results in the enhanced production of ECM components, including collagen types I, III, IV, V, and VI, and fibronectin. This is established as the central event in the development of hepatic fibrosis.
Activated HSC produce wide spectrum of cytokines and respond to their presence via autocrine loop. Transforming growth factor β1 (TGF-β1) is a potent fibrotic factor responsible for the synthesis of the extracellular matrix. TGF-β1 induces the α-SMA expression in fibroblastic cells of various origins (21, 29, 31) . TGF-β1 acts through the TGF-β type I and type II receptors to activate intracellular mediators, such as Smad proteins, the p38 mitogen-activated protein kinase (MAPK), and the extracellular signal-regulated kinase pathway (7, 12) . Related to this signalling pathway are also fibroblast growth factors (FGFs). FGFs consist of seven families. Basic fibroblast growth factor (FGF-2) and acidic fibroblast growth factor (FGF-1) were found to be widely expressed in tissues. FGFs act through four types of tyrosine kinases receptors (FGFR). A unique feature shared by all members of the FGF family is their strong affinity for the glycosaminoglycan heparin. Heparin is necessary for biological activity of FGF-1. Despite the name, little is known about the effect of FGF-1 on myofibroblast. Few studies suggest that FGF-1, unlike FGF-2, displays antifibrotic functions. FGF-1 has been found to downregulate collagen expression and antagonize profibrogenic effects of TGF-β1. FGF-1 inhibits TGF-β1 induced Smad2 phosphorylation (24, 27) , but the mechanism has not been fully elucidated. Our previous study showed that FGF-1 alone decreases the expression of α-SMA and increases the expression of fibronectin (EDA-FN) in fully activated myofibroblasts isolated from a healthy rat liver (22) .
Present work aims to elucidate, whether FGF-1 treatment could result in a deactivation of myofibroblasts. Most of studies dealing with MFB have been conducted in the conventional monolayer culture. Three-dimensional collagen matrices are often used as a model to study cell behaviour 125 in the tissue-like environment (9) . We provided novel assessment of the effect of FGF-1 on HSC-T6 in collagen gel. The TGF-β1 stimulated HSC-T6 cells (immortalised cells which exhibit the typical features of activated HSC) were treated by FGF-1 and evaluated. Our data indicate that FGF-1 could revert the myofibroblastic differentiation.
To evaluate the effect of FGF-1/H(FGF-1 stabilized with heparin), HSC-T6 cells were stimulated with TGF-β1 for 24 h, and then treated with FGF-1/H in persisting presence of TGF-β1 for another 24 h. Nontreated cells were used as a control group. We examined mRNA expression using qPCR. To validate these results we performed the Western blot analysis and the detection of cellular localization of corresponding proteins using immunocytochemistry.
Methods

Cell cultivation
HSC-T6, an immortalized rat hepatic stellate cell line (34) , was kindly gifted from Prof. Weiskirchen, (Institut für Molekulare Pathobiochemie, RWTH Universitätsklinikum Aachen, Germany). HSC-T6 cell line has been known have all features of activated HSC (30) . HSC-T6 were cultured in Dulbecco's modified Eagle medium (DMEM, SigmaAldrich, Prague, Czechia) containing 10% fetal bovine serum (FBS) (PAA, Cölbe, Germany), 4 mM L-glutamine, 100 U/mL penicillin (Sigma-Aldrich). Cells were maintained at 37 °C in 5% CO 2 . After incubation for 24 h in complete DMEM cells were stimulated in serum free medium (SFM) with TGF-β1 (1 ng/ml) for 24 h. To evaluate effect of FGF-1 cells were treated with FGF-1 (4 ng/ml) stabilized with heparin (10 ug/ml) (FGF-1/H) alone or with TGF-β1 (1 ng/ml) for 24 h. Control cells were maintained in SFM. FGF-1 and TGF-β1 were obtained from Peprotech (Rocky Hill, USA), heparin from porcine intestinal mucosa was obtained from Sigma-Aldrich.
Collagen gel
Rat tail collagen type I was prepared as described in Peterova et al. 2016. The cells (60 thousands) were suspended in 2 ml of mixture of sterile collagen solution with 4 × DMEM in the ratio 3:1 (v/v). The gels were allowed to polymerize in the CO 2 incubator for 1 hour at 37 °C in Petri 35 mm dishes. First layer was covered with the same volume of DMEM containing 20% FBS and antibiotics. After incubation for 24 h in complete DMEM cells were stimulated in serum free medium (SFM) with TGF-β1 and FGF-1/H as described elsewhere.
RNA isolation and quantitative reverse transcription polymerase chain reaction (qRT-PCR)
The cells on plastic were washed with phosphate-buffered saline (PBS), harvested and dissolved in RLT lysis buffer (Qiagen, RNeasy Mini kit). Total cellular RNA was extracted by RNeasy Mini kit according to manufacturer instructions (Qiagen, Hilde, Germany). Collagen gel was dissolved by Clostridium histolyticum collagenase NB 4G proved grade (Serva, Heidelberg, Germany). 1 ug of RNA was reverse transcribed using cDNA Reverse Transcription Kit and quantified with TaqMan Gene Expression Assays (TGF β1 Rn00572010_m1, Acta1 Rn01426628_g1, Fndc3a Rn01465936_m1, Col1a2 Rn00584426_m1, MMP2 Rn01538171_m1, TIMP1 Rn00587558_m1) using 7500 Fast Real-Time PCR system (all obtained from Applied Biosystems, Prague, Czechia). The relative expression from four independent experiments performed in duplicates was normalized to 18 s expression.
Western blot analysis
The cells were harvested, suspended in PBS containing 4 mM EDTA and washed 3 times. Collagen gels were dissolved. The proteins were extracted with Cell lysis buffer 10× (Cell Signaling Technology, Danvers, USA). Protein content was determined by Bicinchoninic Acid Protein Assay Kit (Sigma-Aldrich). Forty µg of protein were applied on Novex NuPAGE 4-12% Bis-Tris gel (Invitrogen Life Technologies, Prague, Czechia) under nonreducing conditions. The proteins were transferred to 0.2 mm Hybond nitrocellulose membrane (GE Healthcare, München, Germany). Staining with Ponceau S was used as a loading control. The membranes were incubated with antibodies to α-SMA (1A4, Sigma-Aldrich), cellular fibronectin (IST-9, Santa Cruz Biotechnology, Santa Cruz, USA) or MMP-2 (H-76, Santa Cruz), TIMP-1 (Santa Cruz) at 4 °C overnight. The secondary antibodies were from Santa Cruz. Detection was done with Western Blotting Luminol Reagent (Santa Cruz). The blots were scanned, quantified by program QUANTITY ONE 4.6 (Bio-Rad Laboratories, Hercules, California) and normalized to the respective controls.
Immunocytochemistry
The cells were fixed in 98% ethanol for 10 minutes. They were permeabilized on ice in cold solution of 0.1% Triton X-100 in 0.1% sodium citrate for 5 min. Nonspecific binding sites were blocked by 10% fetal calf serum in PBS for 30 min. The cells were incubated with the primary antibody at 4 °C overnight. Anti-α-smooth muscle actin (α-SMA) clone 1A4 (Sigma-Aldrich) was diluted 1:400. The secondary antibody was Polyclonal Goat Anti-mouse immunoglobulins/HRP (Dako, Glostrup, Denmark); it was diluted 1:100 and the cells were incubated in the dark for 1 hour. Nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI, Sigma-Aldrich) for 2 min. Unspecific mouse immunoglobulins served as negative controls. Cells were washed with PBS, mounted in Vectashield (Vector Laboratories, Burlingame, California) and studied under Nikon Eclipse fluorescent microscope.
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Cytokine induced myofibroblastic conversion and its reversal should be therefore confirmed under condition which could mimic in vivo fibrotic condition. Figure 2 shows the effect of collagen gel cultivation on the expression of myofibroblastic markers during TGF-β1 stimulation and FGF-1/H treatment. Cells were planted into the collagen type I gel. Collagen type I is almost not present in the space of Disse in a healthy liver. It becomes abundant during liver fibrosis progress due to HSC proliferation, activation and myofibroblastic conversion. When grown in collagen gel, HSC-T6 cell tend to clump together. Protrusions radiating from the outer margin of the clump are frequent (Fig. 2C) . The cells in collagen gel responded to TGF-β1 stimulus by an enhanced mRNA expression of α-SMA (3fold). Addition of TGF-β1 did not paracrinally stimulate TGF-β1 gene expression, as seen on plastic. Also, no induction of COL1A2 or fibronectin genes was observed ( Fig. 2A) . Despite of the enhanced α-SMA mRNA expression, we could not detect any changes at a protein level. More interesting is the fact that a control group of cells growing in the collagen gel had highly reduced levels of α-SMA (non-detectable using immunofluorescence, Fig. 2C ) compared to cells grown on plastic. FN-EDA was the only one of the tested markers that behaved in the same way in the cells cultivated on the plastic and in the collagen gel. An upregulation of FN-EDA protein expression after the TGF-β1 treatment was detected; addition of FGF-1/H reduced it.
FGF-1/H effect on the proteolytic phenotype of HSC-T6 on the plastic
ECM remodelling is mostly carried out by the balance between activities of proteinases and their inhibitors. We tested cytokine mediated regulation of gelatinases MMP-2, MMP-9 and tissue inhibitors of MMP (TIMP-1, TIMP-2) on different substrates. Figure 3 shows the effect of TGF-β1 cell stimulation and FGF-1/H treatment on amount of mRNA of MMP-2, MMP-9, TIMP-1, and TIMP-2 (Fig. 3A) . Protein expressions of MMP-2 and TIMP-1 are also shown (Fig. 3B) . TGF-β1 stimulated the mRNA expressions of MMP-2, MMP-9 and TIMP-1 in HSC-T6. FGF-1/H attenuated the expression of TIMP-1 to levels comparable to those expressed by the untreated cells. Western blot showed that MMP-2 and TIMP-1 protein expression did not parallel the changes observed at the mRNA level. Neither the amount of the full-length 72 kDa pro-MMP-2, nor the amount of fully active MMP-2 62 kDa form was changed after the TGF-β1 cell stimulation or the FGF-1/H treatment. TGF-β1 promotes a TIMP-1 protein expression that remained the same after the FGF-1/H treatment. Finally, enzyme activity of MMP-2 and MMP-9 was measured by the gelatin zymography (Fig. 3C) . Sample processing (involving de-and re-naturation) restores active form of the MMP, but also the gives the ability to digest gelatin to the normally inactive pro-MMPs. Gelatinolytic activities corresponding to the latent forms of MMP-2 and MMP-9 were present in conditioned media
Gelatin zymography
Zymographic analysis was performed on conditioned media. The cells cultured on gels were released with trypsin and plated on plastic for 24 hours. The medium was collected and compared with the medium of trypsinized cells cultured previously on plastic only. Protein concentration in the media was adjusted to 1 mg/ml. Ten microliter aliquots were electrophoresed in 8% SDS-polyacrylamide gel containing 0.1% gelatin (Sigma-Aldrich). The gel was washed in 2.5% Triton X-100 for 1 h and subsequently incubated for 15 h at 37 °C in 50 mmol/L Tris-HCl buffer pH 7.4 containing 15 mmol/L sodium chloride and 10 mmol/L calcium chloride. The gel was stained with Coomasie brillant blue and destained with 40% methanol and 10% acetic acid solution. Gelatinolytic bands were size-calibrated with a high molecular mass marker (Bio-Rad).
Statistical analysis
Results are presented as mean ± SD. Statistical significance of differences between groups was tested with one-way ANOVA. Significant results are shown wit asterisk (* P ≤ 0.05; ** P ≤ 0.01). All calculations were performed using GraphPad Prism version 6.00 for Windows, GraphPad Software (San Diego, California USA).
Results
TGF-β1-induced myofibroblastic conversion
is reversed by FGF-1/H Figure 1 shows that stimulation of HSC-T6 with TGF-β1 resulted in an increased mRNA expression of myofibroblast markers TGF-β1 (3 fold) and α-SMA (135 fold), but not that of fibronectin. Non-significant increase in an expression of collagen type I gene COL1A2 was observed. The addition of FGF-1/H decreased the mRNA expression of TGF-β1 to similar levels that were observed in unstimulated cells. No effect of FGF-1/H on mRNA expression of fibronectin or COL1A2 was observed (Fig. 1A) . On the protein level, however, α-SMA and fibronectin protein amounts were changed during the treatment, as confirmed by Western blot and immunohistochemical analysis. Compared with TGF-β1 treated cells, the addition of FGF-1/H led to a drastic decrease of fibronectin and α-SMA protein levels, indicating a positive effect on the antimyofibroblastic conversion (Fig. 1B) . Reduced α-SMA expression after the FGF-1/H treatment (as visualized by immunofluorescence) supported these results. Upon stimulation or FGF1/H treatment the cells did not exhibit any morphological changes; proliferation was also unaffected (data not shown).
Protective effect of collagen gel on FGF-1/H-induced reversal of myofibroblastic activation
The importance of collagen environment on cell behaviour, phenotype and proliferation is widely accepted (10). 
FGF-1/H effect on the proteolytic phenotype of HSC-T6 in the collagen gel
HSC-T6 cells were embedded in the collagen gel, followed by the cytokine stimulation. We found different expression patterns of the non-stimulated cells on the plastic and in the collagen gel. Graph 4 shows mRNA expressions of MMP-2, 9, and TIMP-1, 2 indicated as a percentage of the unstimulated control HSC-T6 seeded on plastic. Planting of the cells into the collagen gel alone dramatically increased MMP-2 expression. No effect of TGF-β1 or FGF-1 on mRNA expression of genes of interest was observed. Western blot analysis revealed that TGF-β1 induced expression of pro-MMP-2, however, most of it remained as a zymogen without being converted to the active form. In the collagen gel, the HSC-T6 cells secrete less MMP-2 and 9 in response to FGF-1 treatment.
Discussion
In the presented work, we demonstrate that FGF-1/H prevents TGF-β1-induced myofibroblastic activation, as evi- denced by decreased levels of α-SMA and FN-EDA. We also provide the evidence that MFB phenotypic switch is modulated by ECM. This finding is consistent with our previous work showing that FGF-1/H alone had a larger effect on MFB phenotype in the cells cultured on plastic than on those in collagen gel (22) . In the previous study, fully activated MFB were generated by outgrowth of primary HSC, isolated from a normal rat liver. MFB and HSC differ in the ability to degrade ECM proteins. MFB represent a cell population with high collagenolytic potential (15) , which HSC-T6 do not have. Thus the HSC-T6 cells can reflect an early phase of the liver damage, when cytokines play a crucial role in the activation of quiescent HSC.
The key cells participating in the development of the liver fibrosis are HSC and MFB. In the intact liver, HSC store retinoids and triacylglycerols in cytoplasmic lipid droplets. After a liver injury, HSC are activated into contractile MFB. Cytokines released from damaged hepatocytes and Kupfer cells are major stimulants (26) . TGF-β1 appears to be responsible for the stimulation of ECM proteins expression and inhibition of their degradation (4, 8) . An important property of TGF-β1 is the ability to induce its own mRNA expression, and thereby multiply its effect (32) . TGF-β1 induces mRNA expression of MFB markers, such as α-SMA, procollagen, and fibronectin (17) . It was 130 proved by others (6) that the α-SMA and FN positive cells are responsible for the overproduction of collagen type I in a fibrotic liver. Moreover, there is a correlation between expressions both proteins. Cellular FN consists of two splicing variants, namely ED-A and ED-B. It was shown that TGF-β1 increases accumulation of the ED-A FN isoform (1) . TGF-β1 induction of ED-A FN is dependent on PI3-kinase-AKT signalling (23) . Our results on HCS-T6 showed that TGF-β1 indeed induced its own mRNA expression and expression of α-SMA, but had no effect on mRNA expression of procollagen I. Increase in fibronectin was detected in the TGF-β1 stimulated cells at the protein level. The effect of FGF-1/H on HSC-T6 was ambiguous. It decreased the TGF-β1 auto-induction, but conversely also potentiated the expression of α-SMA mRNA. More importantly, FGF-1/H reduced α-SMA and fibronectin at protein levels. Our data show that FGF-1 is sufficient to reduce the myofibroblastic differentiation, but the mechanism is not solely based on the downregulation of expression of the related genes. Our findings correspond with previous studies, suggesting that FGF-1 has an antifibrotic role: The myofibroblast phenotype reversal induced by FGF-1/H has been described in lung fibroblasts. Cells treated with FGF-1/H displayed increased apoptosis, decreased collagen production, and α-SMA expression (25). FGF-1 also has the ability to revert EMT by inhibiting Smad2 phosphorylation through the MAPK/ERK pathway (24, 27) .
Cells-to-matrix interaction could modify the phenotype of the myofibroblasts. Therefore, an understanding of this cooperation requires the use of the matrix-derived lattices. Various 2D or 3D matrices were studied in order to determine the influence of ECM on the myofibroblast activation. Collagen gels are used to mimic in vivo fibrotic conditions (10) . It was published that TGF-β1 stimulates a contraction of native collagen gels by HSC, these properties of HSC associated with an increase in α-SMA content. This contraction was dependent on a HSC cell density in the collagen lattices (16) . Others have reported that TGF-β1-induced increase of α-SMA content in a human gingival fibroblasts is dependent on the resistance of the substrate to deformation. Soft environment, represented by floating gels, did not increase mRNA for α-SMA at all (2) . The interaction of the collagen gel fibres with α2β1-integrin may be a restriction factor in stretch-induced α-SMA and FN-EDA regulation. In our study we induced the myofibroblastic phenotype on both substrata -plastic dishes, which represent condition with high tensile strength, and the opposite collagen gel lattice, with a low tensile strength. We show that in HSC-T6 cells TGF-β1 fails to induce the α-SMA protein expression in the collagen gel. The TGF-β1 stimulation appears to associate with an increase in FN-EDA. The FGF-1 treatment was able to markedly reduce this expression. We also provided the evidence that the α-SMA expression is accompanied with the FN-EDA increase on the plastic as suggested by others 131 (14, 33) , but not in the collagen gel. Taken together, myofibroblasts are plastic cells that -if stimulated -can express some (but not all) profibrogenic markers. This expression is modulated by the three-dimensional environment. The FGF-1 treatment could possibly diminish some of these changes.
Proteolysis of ECM is a key player in the resolution of a liver fibrosis. The matrix degradation is achieved by the activity of MMPs, which consists of collagenases, gelatinases, stromelysins, and membrane type (MT)-MMPs. Various cytokines and growth factors, including TGF-β1, control the balance between activators and inhibitors of proteinases. During an acute liver injury elevated levels of TGF-β1, MMP-2, MMP-9, and TIMP-1 were found, suggesting their role in the early ECM remodelling (18) . MMP-9 was found in scaring areas along with the activated HSC (11) . TGF-β1 stimulated expression of MMP-2 and TIMP-1 in vitro in dose dependent manner (19, 20) . In our hands, stimulation of the cells with TGF-β1 promoted MMP-2, MMP-9 and TIMP-1 expression and reduced the expression of TIMP-2, but no changes at the protein level were detected.
According to our previous results we presumed that FGF-1 might influence MMP and TIMP expression. A mild repression of secreted pro-MMP-2 and pro-MMP-9 was seen in culture media in the FGF-1/H treated cells. FGF-1/H presence reduced the TIMP-1 mRNA expression significantly. TIMP-1 is important in the inhibition of collagenase (MMP-1) and MMP-9, while TIMP-2 regulates the activity of MMP-2. Increase in the capacity for ECM turnover by reduction of protease inhibition is the goal of an anti-fibrotic therapy. Previous studies showed that 3D environment rich in type I collagen stimulates the ECM remodelling activities of HSC by induction of MMP-9 (18, 28) . Collagen gel stimulates mRNA expression of MMP-2 as well as its activity in HSC-T6 cells. Mild decrease in secretion of pro-MMP-2 and pro-MMP-9 in the FGF-1/H treated cells was seen.
Conclusion
To address the effect of FGF-1 on myofibroblastic conversion of HSC-T6 cells, thecells were stimulated with TGF-β1. The cells were cultivated in the monolayer cultures or on the collagen gels. FGF-1 significantly reduced levels of FN-EDA in the both environments, and significantly reduced levels of α-SMA on plastic For this reason we conclude that FGF-1 could (by an unknown mechanism) antagonize the signals initiated by TGF-β1; FGF-1 is thus behaving as an antagonist of induction of myofibroblastic features in both plastic and in three-dimensional collagen matrices. FGF-1 represents a possible agent for pharmacological studies on the myofibroblastic activation during pathological events.
